InconclusiveClinical Trial2018
The effects of cannabidiol (CBD) on cognition and symptoms in outpatients with chronic schizophrenia a randomized placebo controlled trial.
Classification Results
AI Classification
InconclusiveFine-tuned Classification
N/A